Uncovering N4-Acetylcytidine-Related mRNA Modification Pattern and Landscape of Stemness and Immunity in Hepatocellular Carcinoma

Uncovering N4-Acetylcytidine-Related mRNA Modification Pattern and Landscape of Stemness and Immunity in Hepatocellular Carcinoma

N4-acetylcytidine (ac4C) is an ancient and conserved RNA modification. Previously, ac4C mRNA modification has been reported promoting proliferation and metastasis of tumor cells. However, it remains unclear whether and how ac4C-related mRNA modification patterns influencing the prognosis of hepatoce...

Full description

Bibliographic Details
Main Authors:	Sicheng Liu, Yaguang Zhang, Lei Qiu, Su Zhang, Yang Meng, Canhua Huang, Zhixin Chen, Bo Zhang, Junhong Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	hepatocellular carcinoma ac4C mRNA modification tumor microenvironment tumor stemness prognosis predictor
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2022.861000/full

Similar Items

NAT10‐mediated mRNA N4‐acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression
by: Cui‐Cui Zhao, et al.
Published: (2024-04-01)

Multi-omics analysis and validation of the tumor microenvironment of hepatocellular carcinoma under RNA modification patterns
by: Yuanqian Yao, et al.
Published: (2023-09-01)

Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression
by: Shujun Zhang, et al.
Published: (2024-01-01)

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
by: Cheng Zhong, et al.
Published: (2021-03-01)

NAT10‐mediated mRNA N4‐acetylcytidine modification promotes bladder cancer progression
by: Ganping Wang, et al.
Published: (2022-05-01)

UTP11 promotes the growth of hepatocellular carcinoma by enhancing the mRNA stability of Oct4
by: Yan Chen, et al.
Published: (2024-01-01)

RNA Modifications Meet Tumors
by: Yang Z, et al.
Published: (2022-11-01)

Chronic Inflammatory and Immune Microenvironment Promote Hepatocellular Carcinoma Evolution
by: Chen S, et al.
Published: (2023-11-01)

Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
by: Shouyi Zhang, et al.
Published: (2023-04-01)

Pulmonary metastasis of hepatocellular carcinoma: pathogenesis and therapeutic advances
by: GUAN Tao, ZHANG Ti, WANG Lu
Published: (2022-05-01)

A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment
by: Chunting Zeng, et al.
Published: (2022-06-01)

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2023-11-01)

Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
by: Hsin-Lun Lee, et al.
Published: (2023-07-01)

Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
by: Xiaokun Chen, et al.
Published: (2023-10-01)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
by: Zhuomao Mo, et al.
Published: (2021-02-01)

Macrophages and hepatocellular carcinoma
by: Zhiqiang Tian, et al.
Published: (2019-09-01)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
by: Kun Zhao, et al.
Published: (2022-11-01)

mRNA vaccine development for cholangiocarcinoma: a precise pipeline
by: Tian-Yu Tang, et al.
Published: (2022-07-01)

The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
by: Camilla Volponi, et al.
Published: (2022-12-01)

Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma
by: Jianping Zhang, et al.
Published: (2023-01-01)

Uridine Inhibits Hepatocellular Carcinoma Cell Development by Inducing Ferroptosis
by: Liuliu Zi, et al.
Published: (2023-05-01)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
by: Maria Kotsari, et al.
Published: (2023-07-01)

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
by: Pil Soo Sung
Published: (2022-07-01)

Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma
by: Qunfang Zhang, et al.
Published: (2020-01-01)

m7G regulator-mediated methylation modification patterns define immune cell infiltration and patient survival
by: Lu Wang, et al.
Published: (2022-10-01)

Dissection of mRNA ac4C acetylation modifications in AC and Nr fruits: insights into the regulation of fruit ripening by ethylene
by: Lili Ma, et al.
Published: (2024-02-01)

Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma
by: Ming-Cheng Guan, et al.
Published: (2022-09-01)

Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
by: Zi-An Chen, et al.
Published: (2021-09-01)

Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma
by: Yuanfei Lu, et al.
Published: (2022-08-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Albert Liu, et al.
Published: (2022-07-01)

NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma
by: Yu-Mei Ning, et al.
Published: (2022-08-01)

Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma
by: Haohan Zhang, et al.
Published: (2022-07-01)

A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer
by: Qiangan Jing, et al.
Published: (2023-02-01)

Editorial: The role of tumor microenvironment in the development, treatment and prognosis of hepatocellular carcinoma
by: Haiyu Wang, et al.
Published: (2024-01-01)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
by: Luo M, et al.
Published: (2021-08-01)

A High-Throughput Sequencing Data-Based Classifier Reveals the Metabolic Heterogeneity of Hepatocellular Carcinoma
by: Maolin Ye, et al.
Published: (2023-01-01)

Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
by: Lin Qi, et al.
Published: (2022-07-01)

Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
by: Mengjiao Xu, et al.
Published: (2022-09-01)

N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
by: Lei Zhan, et al.
Published: (2021-09-01)

The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
by: Xinyi Zhang, et al.
Published: (2023-12-01)